|
1
|
Burma NE, Leduc-Pessah H, Fan CY and Trang
T: Animal models of chronic pain: Advances and challenges for
clinical translation. J Neurosci Res. 95:1242–1256. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
North RY, Li Y, Ray P, Rhines LD, Tatsui
CE, Rao G, Johansson CA, Zhang H, Kim YH, Zhang B, et al:
Electrophysiological and transcriptomic correlates of neuropathic
pain in human dorsal root ganglion neurons. Brain. 142:1215–1226.
2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chen G, Kim YH, Li H, Luo H, Liu DL, Zhang
ZJ, Lay M, Chang W, Zhang YQ and Ji RR: PD-L1 inhibits acute and
chronic pain by suppressing nociceptive neuron activity via PD-1.
Nat Neurosci. 20:917–926. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Alles SRA and Smith PA: Etiology and
pharmacology of neuropathic pain. Pharmacol Rev. 70:315–347.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Villarreal CF, Sachs D, Funez MI, Parada
CA, de Queiroz Cunha F and Ferreira SH: The peripheral
pro-nociceptive state induced by repetitive inflammatory stimuli
involves continuous activation of protein kinase A and protein
kinase C epsilon and its Na(V)1.8 sodium channel functional
regulation in the primary sensory neuron. Biochem Pharmacol.
77:867–877. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sommer C, Leinders M and Üçeyler N:
Inflammation in the pathophysiology of neuropathic pain. Pain.
159:595–602. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang H, Xu H, Wu LJ, Kim SS, Chen T, Koga
K, Descalzi G, Gong B, Vadakkan KI, Zhang X, et al: Identification
of an adenylyl cyclase inhibitor for treating neuropathic and
inflammatory pain. Sci Transl Med. 3(65ra3)2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Todd AJ: Neuronal circuitry for pain
processing in the dorsal horn. Nat Rev Neurosci. 11:823–836.
2010.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Kennedy PGE and Gershon AA: Clinical
features of varicella-zoster virus infection. Viruses.
10(10)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cunha C, Silva AJ, Pereira P, Vaz R,
Gonçalves RM and Barbosa MA: The inflammatory response in the
regression of lumbar disc herniation. Arthritis Res Ther.
20(251)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang JG, Strong JA, Xie W and Zhang JM:
Local inflammation in rat dorsal root ganglion alters excitability
and ion currents in small-diameter sensory neurons. Anesthesiology.
107:322–332. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Strong JA, Xie W, Coyle DE and Zhang JM:
Microarray analysis of rat sensory ganglia after local inflammation
implicates novel cytokines in pain. PLoS One.
7(e40779)2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lin JS and Lai EM: Protein-protein
interactions: Co-immunoprecipitation. Methods Mol Biol.
1615:211–219. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
National Research Council (US): Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. 8th
edition. National Academies Press, Washington, DC, 2011.
|
|
16
|
Xu F, Yang J, Lu F, Liu R, Zheng J, Zhang
J, Cui W, Wang C, Zhou W, Wang Q, et al: Fast green FCF alleviates
pain hypersensitivity and down-regulates the levels of spinal P2X4
expression and pro-inflammatory cytokines in a rodent inflammatory
pain model. Front Pharmacol. 9(534)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xie W, Strong JA, Kim D, Shahrestani S and
Zhang JM: Bursting activity in myelinated sensory neurons plays a
key role in pain behavior induced by localized inflammation of the
rat sensory ganglion. Neuroscience. 206:212–223. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Oh SB, Tran PB, Gillard SE, Hurley RW,
Hammond DL and Miller RJ: Chemokines and glycoprotein120 produce
pain hypersensitivity by directly exciting primary nociceptive
neurons. J Neurosci. 21:5027–5035. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li HL, Huang Y, Zhou YL, Teng RH, Zhou SZ,
Lin JP, Yang Y, Zhu SM, Xu H and Yao YX: C-X-C motif chemokine 10
contributes to the development of neuropathic pain by increasing
the permeability of the blood-spinal cord barrier. Front Immunol.
11(477)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Müller M, Carter S, Hofer MJ and Campbell
IL: Review: The chemokine receptor CXCR3 and its ligands CXCL9,
CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and
conundrum. Neuropathol Appl Neurobiol. 36:368–387. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tokunaga R, Zhang W, Naseem M, Puccini A,
Berger MD, Soni S, McSkane M, Baba H and Lenz HJ: CXCL9, CXCL10,
CXCL11/CXCR3 axis for immune activation - A target for novel cancer
therapy. Cancer Treat Rev. 63:40–47. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sun RM, Wei J, Wang SS, Xu GY and Jiang
GQ: Upregulation of lncRNA-NONRATT021203.2 in the dorsal root
ganglion contributes to cancer-induced pain via CXCL9 in rats.
Biochem Biophys Res Commun. 524:983–989. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu XB, He LN, Jiang BC, Shi H, Bai XQ,
Zhang WW and Gao YJ: Spinal CXCL9 and CXCL11 are not involved in
neuropathic pain despite an upregulation in the spinal cord
following spinal nerve injury. Mol Pain: May 22, 2018.
|
|
25
|
Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang
ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, et al: Distinct roles
of matrix metalloproteases in the early- and late-phase development
of neuropathic pain. Nat Med. 14:331–336. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Liou JT, Sum DC, Liu FC, Mao CC, Lai YS
and Day YJ: Spatial and temporal analysis of nociception-related
spinal cord matrix metalloproteinase expression in a murine
neuropathic pain model. J Chin Med Assoc. 76:201–210.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rojewska E, Popiolek-Barczyk K, Jurga AM,
Makuch W, Przewlocka B and Mika J: Involvement of pro- and
antinociceptive factors in minocycline analgesia in rat neuropathic
pain model. J Neuroimmunol. 277:57–66. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhao L, Song C, Huang Y, Lei W and Sun J:
MMP-9 regulates CX3CL1/CX3CR1 in the early phase of neuropathic
pain in chronic sciatic nerve constriction injury (CCI) rats. Ann
Palliat Med. 9:2020–2027. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Fritzinger DC and Benjamin DE: The
complement system in neuropathic and postoperative pain. Open Pain
J. 9:26–37. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Jang JH, Clark DJ, Li X, Yorek MS, Usachev
YM and Brennan TJ: Nociceptive sensitization by complement C5a and
C3a in mouse. Pain. 148:343–352. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Xu J, Zhang L, Xie M, Li Y, Huang P,
Saunders TL, Fox DA, Rosenquist R and Lin F: Role of complement in
a rat model of paclitaxel-induced peripheral neuropathy. J Immunol.
200:4094–4101. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Basbaum AI, Bautista DM, Scherrer G and
Julius D: Cellular and molecular mechanisms of pain. Cell.
139:267–284. 2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Woolf CJ: Central sensitization:
Implications for the diagnosis and treatment of pain. Pain. 152
(Suppl 3):S2–S15. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dawes JM, Calvo M, Perkins JR, Paterson
KJ, Kiesewetter H, Hobbs C, Kaan TK, Orengo C, Bennett DL and
McMahon SB: CXCL5 mediates UVB irradiation-induced pain. Sci Transl
Med. 3(90ra60)2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Slade GD, Conrad MS, Diatchenko L, Rashid
NU, Zhong S, Smith S, Rhodes J, Medvedev A, Makarov S, Maixner W,
et al: Cytokine biomarkers and chronic pain: Association of genes,
transcription, and circulating proteins with temporomandibular
disorders and widespread palpation tenderness. Pain. 152:2802–2812.
2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Padi SSV, Shi XQ, Zhao YQ, Ruff MR,
Baichoo N, Pert CB and Zhang J: Attenuation of rodent neuropathic
pain by an orally active peptide, RAP-103, which potently blocks
CCR2- and CCR5-mediated monocyte chemotaxis and inflammation. Pain.
153:95–106. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liou JT, Lee CM and Day YJ: The immune
aspect in neuropathic pain: Role of chemokines. Acta Anaesthesiol
Taiwan. 51:127–132. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Matsushita K, Tozaki-Saitoh H, Kojima C,
Masuda T, Tsuda M, Inoue K and Hoka S: Chemokine (C-C motif)
receptor 5 is an important pathological regulator in the
development and maintenance of neuropathic pain. Anesthesiology.
120:1491–1503. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Szabo I, Chen XH, Xin L, Adler MW, Howard
OM, Oppenheim JJ and Rogers TJ: Heterologous desensitization of
opioid receptors by chemokines inhibits chemotaxis and enhances the
perception of pain. Proc Natl Acad Sci USA. 99:10276–10281.
2002.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Akgün E, Javed MI, Lunzer MM, Powers MD,
Sham YY, Watanabe Y and Portoghese PS: Inhibition of inflammatory
and neuropathic pain by targeting a Mu opioid receptor/chemokine
receptor5 heteromer (MOR-CCR5). J Med Chem. 58:8647–8657.
2015.PubMed/NCBI View Article : Google Scholar
|
